Woolford J, McAuliffe A, Rohrschneider L R
Department of Cell Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Cell. 1988 Dec 23;55(6):965-77. doi: 10.1016/0092-8674(88)90242-5.
The v-fms oncogene is capable of producing tumors in vivo and transforming cells in culture; in contrast, the c-fms proto-oncogene is nontransforming. In this report we present the complete nucleotide sequence of a feline c-fms cDNA, the progenitor of the v-fms oncogene. Comparison of this sequence with that of v-fms shows that the proteins encoded by these two genes differ by nine amino acid substitutions and the replacement of 50 C-terminal amino acids present in c-fms by 11 unrelated residues in v-fms. Using chimeric fms genes and site-directed mutagenesis, we have determined that the C-terminal modification present in v-fms is sufficient to generate a partially transforming phenotype, but that mutations at amino acid positions 301 and 374 are required (in addition to the C-terminal modification) to generate a fully transforming fms gene.
v-fms癌基因能够在体内产生肿瘤并在培养中转化细胞;相比之下,c-fms原癌基因则无转化能力。在本报告中,我们展示了猫科动物c-fms cDNA(v-fms癌基因的前身)的完整核苷酸序列。将该序列与v-fms的序列进行比较表明,这两个基因编码的蛋白质存在9个氨基酸替换差异,并且c-fms中存在的50个C末端氨基酸被v-fms中11个不相关的残基所取代。利用嵌合fms基因和定点诱变技术,我们已确定v-fms中存在的C末端修饰足以产生部分转化表型,但要产生完全转化的fms基因,还需要氨基酸位置301和374处的突变(除C末端修饰外)。